NASDAQ:ZNTL | EBITDA | Zentalis Pharmaceuticals, Inc.

Complete source-backed ebitda history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30-$44.24M
2026-03-31-$37.7M
2025-12-31-$37.24M
2025-09-30-$33.57M
2025-06-30-$35.9M
2025-03-31-$45.36M
2024-12-31-$49.53M
2024-09-30-$51.11M
2024-06-30-$64.82M
2024-03-31-$24.44M
2023-12-31-$67.59M
2023-09-30-$62.37M
2023-06-30-$103.57M
2023-03-31-$64.59M
2022-12-31-$51.4M
2022-09-30-$53.82M
2022-06-30-$63.11M
2022-03-31-$57.54M
2021-12-31-$47.98M
2021-09-30-$62.73M
2021-06-30-$55.01M
2021-03-31-$50.27M
2020-12-31-$40.21M
2020-09-30-$34.72M
2020-06-30-$27.34M
2020-03-31-$16.36M
2019-12-31-$14.86M
2019-09-30-$12.56M
2019-06-30-$10.61M
2019-03-31-$8.7M

Annual EBITDA

DateEBITDA
2025-12-31-$152.07M
2024-12-31-$189.91M
2023-12-31-$298.12M
2022-12-31-$225.86M
2021-12-31-$216M
2020-12-31-$118.63M
2019-12-31-$46.73M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.